How should I manage a 34-year-old male with inflammatory back pain, elevated C‑reactive protein, and negative rheumatoid factor and anti‑CCP antibodies?

Management of Seronegative Inflammatory Back Pain

In a 34-year-old male with inflammatory back pain and elevated CRP but negative RF and anti-CCP antibodies, you should pursue axial spondyloarthritis (axSpA) as the primary diagnosis rather than rheumatoid arthritis, and proceed with sacroiliac joint imaging (MRI preferred) to confirm the diagnosis. 1

Why This Is Not Rheumatoid Arthritis

The negative RF and anti-CCP antibodies effectively rule out rheumatoid arthritis in this clinical context. RF and anti-CCP are the hallmark serologic markers for RA, and their absence—combined with the presentation of back pain rather than peripheral joint involvement—makes RA extremely unlikely 2, 3. RA typically presents with symmetric peripheral arthritis, not isolated inflammatory back pain.

Why This Is Likely Axial Spondyloarthritis

Your patient's presentation is classic for axSpA:

• Age <40 years (he's 34)
• Inflammatory back pain pattern (the "strongly back inflammatory arthritis" description)
• Elevated inflammatory markers (CRP 3.7 mg/dL)
• Seronegative profile (RF and anti-CCP negative, which is expected in axSpA)

The ACR guidelines specifically address this exact clinical scenario 1. Approximately 61% of patients with painful axial AS have elevated CRP 4, and your patient fits this profile. Importantly, 74-89% of axSpA patients are HLA-B27 positive 1, but seronegativity for RF/anti-CCP is the norm in this condition.

Diagnostic Algorithm

1. Order HLA-B27 testing - This has strong genetic association with axSpA (positive in 74-89% of cases) 1

2. Obtain imaging of sacroiliac joints:

   • MRI is preferred for early disease detection (can show bone marrow edema, enthesitis, and synovitis before radiographic changes appear)
   • Plain radiographs if MRI unavailable, though they may be normal early in disease course
   • The sacroiliac joints are classically involved first in axSpA 1

3. Assess for peripheral manifestations:

   • 30-50% of axSpA patients have peripheral arthritis or enthesitis 1
   • Examine for psoriasis, inflammatory bowel disease symptoms, or uveitis

4. Document inflammatory back pain features:

   • Insidious onset
   • Improvement with exercise
   • No improvement with rest
   • Nocturnal pain
   • Morning stiffness >30 minutes

Clinical Pitfalls to Avoid

• Don't dismiss the diagnosis because of negative serology - axSpA is characteristically seronegative for RF and anti-CCP
• Don't wait for radiographic changes - there is a mean diagnostic delay of 4.9 years from symptom onset 1, partly because radiographic sacroiliitis develops slowly over years
• Don't confuse this with mechanical back pain - the elevated CRP (3.7) supports an inflammatory process 4

Treatment Considerations While Awaiting Confirmation

The elevated CRP indicates active inflammation. NSAIDs/coxibs have demonstrated significant treatment effect on CRP in axSpA patients, with greater magnitude of effect in those with elevated baseline CRP 4. Consider initiating NSAID therapy at anti-inflammatory doses while completing the diagnostic workup, as this addresses both symptoms and the inflammatory process.

The CRP level correlates positively with disease activity (BASDAI) and functional impairment (BASFI) in axSpA 4, making it a useful marker for both diagnosis and monitoring treatment response in your patient.